Otros idiomas Genscript Biotech Corporation

Acciones

1548

KYG3825B1059

Biotecnología e investigación médica

Mercado cerrado - Hong Kong S.E. Otros sitios de cotización 10:08:25 19/05/2025			Varia. Cinco días.	Varia. 1 de enero.
10,44 ^HKD	+2,35 %		-1,32 %	+6,10 %

16/04	Genscript Biotech Associate registra 369 millones de dólares en ventas de CARVYKTI en el primer trimestre	MT
09/04	Las acciones de Hong Kong invierten las pérdidas iniciales y terminan al alza; las acciones farmacéuticas caen	MT

Otros idiomas

Genscript Biotech Associate Logs $369 Million in Q1 Sales of CARVYKTI	16/04
Hong Kong Stocks Reverse Early Losses to End Higher; Pharma Stocks Slide	09/04
Hong Kong Pharma Stocks Decline as Trump Threatens Tariffs on Imported Drugs	09/04
GenScript Unveils Prime Editing Boost with the Broad Institute Deal	19/03
GenScript Biotech Corporation Reports FY 2024 Results	12/03
Genscript Biotech Swings to Profit in 2024; Shares Down 4%	12/03
Genscript Biotech Corporation Reports Earnings Results for the Full Year Ended December 31, 2024	12/03
Genscript Biotech Corporation Announces Board and Board Committee Changes	11/03
Genscript Biotech Expects Higher 2024 Net Profit	17/02
Genscript Biotech Corporation Announces Establishment of A Sub-Committee of the Risk Management and ESG Committee	10/02
Genscript Biotech's Associate Logs $334 Million in Carvykti Drug Sales in Q4	23/01
GenScript upgrades product packaging with a recyclable strategy, reducing waste by 82% and contributing to environmental sustainability	15/01
Genscript Biotech's Rotating CEO Steps Down	02/12
Shanghai Xuanren Technology Co., Ltd. announced that it has received funding from Huatai Zijin Investment Co. Ltd, Genscript Biotech Corporation, Shunwei, Inc.	02/12
The GenScript Biotech Global Forum Makes a Strong Debut in Europe, Highlighting Breakthroughs in Cell and Gene Therapy Development	21/11
GenScript Subsidiary ProBio Instrumental in Latest Fight Against Cancer	15/11
Genscript Biotech Enters Sub-License Contract for Anti-PD-1 Single Domain Antibodies	15/11
Genscript Biotech Corporation Appoints Aylin Kosova Bilgin Has Joined as the First-Ever Chief Marketing Officer for GenScript Life Science Group	13/11
Genscript Bio Associate Legend Biotech's Loss Doubles in Q3	13/11
Genscript Biotech Unit Logs $286 Million in Sales from Carvykti in July-September	16/10/24
GenScript Biotech Advances Sustainable Development with MSCI ESG Rating Upgrade to A	14/10/24
Genscript Biotech Corporation Announces Late-Breaking Long-Term Overall Survival Data from Cartitude-4 Study in Multiple Myeloma	29/09/24
GenScript Appoints New Board Members to Drive Global Growth	12/09/24
Genscript Biotech Corporation Announces Board Appointments	12/09/24
GenScript Subsidiary Legend Biotech Achieves Breakthrough with Cilta-cel Approval in China, Offering New Hope for Multiple Myeloma Patients	28/08/24

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Genscript Biotech Corporation

Acciones

1548

KYG3825B1059

Biotecnología e investigación médica

Otros idiomas

Filtros